IL6 and colorectal carcinoma: Furthermore, scientific data show the upregulation of serum IL-6 in CRC, which correlates with the tumor size [47,48] but, also, with poor prognosis in metastatic colon cancer patients [49,50] and treatment-refractory carcinomas [51,52].